Page last updated: 2024-11-04

suramin and Cancer of Esophagus

suramin has been researched along with Cancer of Esophagus in 1 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Research Excerpts

ExcerptRelevanceReference
"Since human esophageal squamous cell carcinoma expresses abundant epidermal growth factor receptors (EGFR) and proliferates in an autocrine and paracrine manner, it was expected that suramin inhibits tumor growth by disrupting EGFR."1.30Effect of suramin on human esophageal cancer cells in vitro and in vivo. ( Kamikawa, Y; Naomoto, Y; Orita, K; Shin, R; Tanaka, N, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shin, R1
Naomoto, Y1
Kamikawa, Y1
Tanaka, N1
Orita, K1

Other Studies

1 other study available for suramin and Cancer of Esophagus

ArticleYear
Effect of suramin on human esophageal cancer cells in vitro and in vivo.
    Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:8

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Disease Models, Animal; Dos

1997